Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease - Concepedia

Concepedia

Publication | Closed Access

Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease

164

Citations

48

References

2008

Year

Azhar Ansari, M Arenas, Simon Greenfield, David L. Morris, James O. Lindsay, Kristen Gilshenan, Melissa Smith, Cathryn M. Lewis, Anthony M. Marinaki, J. A. Duley,

Alimentary Pharmacology & Therapeutics

Abstract

TPMT testing predicts adverse effects and reduced chance of clinical response (TPMT >35 pmol/h/mg/Hb). ITPase deficiency is a predictor of adverse effects and TGN concentrations above 100 correlate with clinical response.

References

	Year	Citations

Page 1